European Society of Cardiology issues consensus statement on inflammation in atherosclerosis
How low is too low? Experts debate blood pressure targets in post-SPRINT era
Following the landmark SPRINT trial, there is a growing body of evidence for reducing systolic blood pressure targets, resulting in the development of new US guidelines. However, this has led to many questions about the impact of such fundamental changes in blood pressure management, and whether they should be implemented in other constituencies.
A fat belly is bad for your heart
Vegetables may help protect elderly women from hardening of neck arteries
Heart attack protocol can improve outcomes and reduce disparities between men and women
New EHRA Practical Guide on non-vitamin K antagonist oral anticoagulants launched
Stress of open-heart surgery significantly reduces vitamin D levels, but supplementation helps
Alirocumab reduces cardiovascular events after acute coronary syndrome
Statins may bring benefits at time of treatment for percutaneous coronary intervention
Getting a large dose of a statin did not have an impact on major adverse cardiac events among a broad population of patients slated to undergo percutaneous coronary intervention (PCI), but statins did significantly reduce the rates of such events among the subset of trial participants who actually underwent PCI.